Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121037794 | 12103779 | 4 | F | 20160114 | 20160720 | 20160223 | 20160728 | EXP | CA-ALEXION PHARMACEUTICALS INC-A201601085 | ALEXION | 9.46 | YR | M | Y | 56.20000 | KG | 20160728 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121037794 | 12103779 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, QW | Y | AD6569B03 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | ||||
| 121037794 | 12103779 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 1200 MG, Q2W | Y | AD7698B01 00:00 | 125166 | 1200 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | ||||
| 121037794 | 12103779 | 3 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 1200 MG, Q2W | Y | AD9022B01 | 125166 | 1200 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | ||||
| 121037794 | 12103779 | 4 | C | PENICILLIN /00000901/ | PENICILLIN G | 1 | Unknown | UNK | 0 | ||||||||||
| 121037794 | 12103779 | 5 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 325-650 MG, 4H PRN | 0 | /yr |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121037794 | 12103779 | 1 | Haemolytic uraemic syndrome |
| 121037794 | 12103779 | 4 | Prophylaxis |
| 121037794 | 12103779 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121037794 | 12103779 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121037794 | 12103779 | Blood alkaline phosphatase abnormal | |
| 121037794 | 12103779 | Device related thrombosis | |
| 121037794 | 12103779 | Nasopharyngitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121037794 | 12103779 | 1 | 20150728 | 20150820 | 0 | |
| 121037794 | 12103779 | 2 | 20150827 | 0 | ||
| 121037794 | 12103779 | 3 | 20150827 | 20160713 | 0 | |
| 121037794 | 12103779 | 4 | 201507 | 0 |